Tag: Viking Therapeutics

Viking Therapeutics shares surged during Monday's pre-market session, climbing nearly 4% as takeover speculation intensified and upcoming clinical milestones drew ...

Viking Therapeutics shares experienced a significant rally over the weekend, propelled by mounting speculation about a potential company acquisition. The ...

Viking Therapeutics shares surged dramatically to close the week, posting a substantial 6.60% gain to reach $29.72. This latest advance ...

Viking Therapeutics shares are experiencing a substantial upward trend, with Friday's trading session delivering a 6.60% gain to reach $29.72. ...

After months of market volatility, Viking Therapeutics is demonstrating renewed investor confidence. During the latest trading session, the biotech firm's ...

Viking Therapeutics has captured significant market attention with its recent stock performance, demonstrating strong upward momentum following analyst confirmation of ...

Viking Therapeutics shares delivered a contradictory performance on Tuesday, advancing 1.86 percent to reach $27.88 and outpacing the S&P 500's ...

The obesity treatment market is witnessing renewed speculation around potential consolidation, with Viking Therapeutics positioned at the center of these ...

Viking Therapeutics finds itself at a critical investment crossroads, pulled in opposite directions by two powerful market forces. Soaring takeover ...

Viking Therapeutics finds itself navigating complex challenges as it advances its obesity treatment portfolio. The company's oral drug candidate, VK2735, ...